Profile
Melissa Downs is currently working as a Senior Director-External Communications at Lantheus Holdings, Inc. She previously worked as an Investor Relations Contact at Progenics Pharmaceuticals, Inc.
Melissa Downs active positions
| Companies | Position | Start |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Public Communications Contact | 01/08/2020 |
Former positions of Melissa Downs
| Companies | Position | End |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Melissa Downs
